Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2026-01-04 @ 2:02 AM
Study NCT ID:
NCT06607757
Status:
RECRUITING
Last Update Posted:
2025-04-02
First Post:
2024-06-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer
Sponsor:
GBG Forschungs GmbH
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | CCCA Assessed by Ki67 Drop Below <2.7% From Baseline | View |
Keywords: